82 related articles for article (PubMed ID: 29391110)
21. Genetics and the clinical approach to paragangliomas.
Schulte KM; Talat N; Galata G; Aylwin S; Izatt L; Eisenhofer G; Barthel A; Bornstein SR
Horm Metab Res; 2014 Dec; 46(13):964-73. PubMed ID: 25014332
[TBL] [Abstract][Full Text] [Related]
22. Predicting survival for well-differentiated liposarcoma: the importance of tumor location.
Smith CA; Martinez SR; Tseng WH; Tamurian RM; Bold RJ; Borys D; Canter RJ
J Surg Res; 2012 Jun; 175(1):12-7. PubMed ID: 21920555
[TBL] [Abstract][Full Text] [Related]
23. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.
Badgwell B; Blum M; Estrella J; Chiang YJ; Das P; Matamoros A; Fournier K; Mansfield P; Ajani J
J Am Coll Surg; 2015 Jul; 221(1):83-90. PubMed ID: 26002780
[TBL] [Abstract][Full Text] [Related]
24. Patterns and management of distant failure in locally advanced rectal cancer: a cohort study.
Arredondo J; Baixauli J; Rodríguez J; Beorlegui C; Arbea L; Zozaya G; Torre W; -Cienfuegos JA; Hernández-Lizoáin JL
Clin Transl Oncol; 2016 Sep; 18(9):909-14. PubMed ID: 26666769
[TBL] [Abstract][Full Text] [Related]
25. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
[TBL] [Abstract][Full Text] [Related]
26. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
[TBL] [Abstract][Full Text] [Related]
27. Patterns of care and survival outcomes in the treatment of esophageal melanoma.
Weiner JP; Shao M; Schwartz D; Wong A; Schreiber D
Dis Esophagus; 2017 Feb; 30(2):1-6. PubMed ID: 27862623
[TBL] [Abstract][Full Text] [Related]
28. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
[TBL] [Abstract][Full Text] [Related]
29. Resection of Intrathoracic Paraganglioma With and Without Cardiopulmonary Bypass.
Gurrieri C; Butz JJ; Weingarten TN; Bancos I; Young WF; Cassivi SD; Said SM; McKenzie TJ; Barbara DW; Sprung J
Ann Thorac Surg; 2018 Apr; 105(4):1160-1167. PubMed ID: 29452998
[TBL] [Abstract][Full Text] [Related]
30. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
[TBL] [Abstract][Full Text] [Related]
32. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
[TBL] [Abstract][Full Text] [Related]
33. Role of 18F-DOPA PET/CT in diagnosis and follow-up of adrenal and extra-adrenal paragangliomas.
Bacca A; Chiacchio S; Zampa V; Carrara D; Duce V; Congregati C; Simi P; Taddei S; Materazzi G; Volterrani D; Mariani G; Bernini G
Clin Nucl Med; 2014 Jan; 39(1):14-20. PubMed ID: 24300347
[TBL] [Abstract][Full Text] [Related]
34. Paraganglioma with a very rare presentation.
Khare M; Gupta MK; Sharma UB; Garg KM
Indian J Pathol Microbiol; 2018; 61(3):404-406. PubMed ID: 30004066
[TBL] [Abstract][Full Text] [Related]
35. The demographic features, clinicopathologic characteristics, treatment outcome and disease-specific prognostic factors of solitary fibrous tumor: a population-based analysis.
Wushou A; Jiang YZ; Liu YR; Shao ZM
Oncotarget; 2015 Dec; 6(39):41875-83. PubMed ID: 26496033
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in alveolar soft part sarcoma: A SEER analysis.
Wang H; Jacobson A; Harmon DC; Choy E; Hornicek FJ; Raskin KA; Chebib IA; DeLaney TF; Chen YL
J Surg Oncol; 2016 Apr; 113(5):581-6. PubMed ID: 26804150
[TBL] [Abstract][Full Text] [Related]
37. Five- and 10-Year Cause-Specific Survival Rates in Carcinoma of the Minor Salivary Gland.
Baddour HM; Fedewa SA; Chen AY
JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):67-73. PubMed ID: 26632951
[TBL] [Abstract][Full Text] [Related]
38. Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer.
Wang LY; Palmer FL; Nixon IJ; Thomas D; Patel SG; Shaha AR; Shah JP; Tuttle RM; Ganly I
Thyroid; 2014 Nov; 24(11):1594-9. PubMed ID: 25162180
[TBL] [Abstract][Full Text] [Related]
39. A prognostic model for resectable soft tissue and cutaneous angiosarcoma.
Sinnamon AJ; Neuwirth MG; McMillan MT; Ecker BL; Bartlett EK; Zhang PJ; Kelz RR; Fraker DL; Roses RE; Karakousis GC
J Surg Oncol; 2016 Oct; 114(5):557-563. PubMed ID: 27378102
[TBL] [Abstract][Full Text] [Related]
40. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study.
Ecker BL; McMillan MT; Datta J; Dempsey DT; Karakousis GC; Fraker DL; Drebin JA; Mamtani R; Giantonio BJ; Roses RE
Eur J Cancer; 2016 Dec; 69():135-141. PubMed ID: 27821316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
